Načítá se...
Prenatal enzyme replacement therapy for Akp2(−/−) mice with lethal hypophosphatasia
Hypophosphatasia (HPP) is a congenital skeletal disease. Impairment of bone mineralization and seizures are due to a deficiency of tissue-nonspecific alkaline phosphatase (TNAP). Enzyme replacement therapy (ERT) is available as a highly successful treatment for pediatric-onset HPP. However, the pote...
Uloženo v:
| Vydáno v: | Regen Ther |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Japanese Society for Regenerative Medicine
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8267436/ https://ncbi.nlm.nih.gov/pubmed/34277899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.reth.2021.06.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|